TRADING UPDATES: Porvair, Brickability start 2021 with solid trading Tue, 20th Apr 2021 18:31 (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Renalytix AI PLC - Cardiff, Wales-based clinical diagnostics company - Says new study in KidneyIntelX test "accurately predicted" progression of diabetic kidney disease in a multinational cohort from the CANagliflozin CardioVAScular Assessment Study with early-stage DKD. "The clinical outcome data suggests that KidneyIntelX risk assessment could support primary care physicians in making appropriate therapeutic intervention decisions with early-stage DKD patients to effectively delay progression and reduce the risk of adverse events," company says. Results presented showed comparable risk-stratification with prior validation studies, company adds.